Meryem Dişli
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Meryem Dişli has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Erdem Yesilada
Department of Pharmacognosy, Faculty of Pharmacy, Yeditepe University, İstanbul, Turkey
1 shared publication - Gulsen Celebi
Department of Pharmacology, Faculty of Medicine, Kocaeli University, Kocaeli, Turkey
1 shared publication - Gökhan Duruksu
Department of Stem Cell, Institute of Health Sciences, Kocaeli University, 41001, Kocaeli, Turkey
1 shared publication - Selenay Furat
Center for Stem Cell and Gene Therapies Research and Practice, Kocaeli University, 41001 İzmit, Kocaeli, Turkey
1 shared publication - Tijen Utkan
Kocaeli University, Faculty of Medicine. Department of Pharmacology
1 shared publication - Zehra Seda Halbutoğulları
Department of Medical Biology, Faculty of Medicine, Kocaeli University, 41001 İzmit, Kocaeli, Turkey
1 shared publication
Latest Publications
- Open Access
- 20 October 2026
- Published by MDPI AG in Biomedicines
- Vol. 14 (10) , 2394
Peri-Ovarian Mitochondrial Administration Improves Surrogate Markers of Ovarian Function in Aged Rats: Free Versus Alginate-Encapsulated Mesenchymal Stromal Cell-Derived Mitochondria
Background: Ovarian aging is driven in part by mitochondrial dysfunction, and transfer of exogenous mitochondria has been proposed as a cell-free alternative to stem cell therapy; whether the delivery format alters efficacy has not been tested directly. Methods: We compared free and alginate-encapsulated mitochondria isolated from rat bone marrow-derived mesenchymal stromal cells (BM-MSCs) in aged rats. Mitochondria retained their membrane potential after encapsulation; approximately 35% of the encapsulated protein was released within 1 h in vitro, and release was complete by 24 h. Thirty-five female Wistar rats were allocated to five groups (n = 7): young control (Y-Ctrl), aged control (O-Ctrl), and three aged subgroups receiving empty capsules (Alg), free mitochondria (MSC-Mito), or encapsulated mitochondria (MSC-Mito@Alg), administered peri-ovarianly and evaluated on day 14. Results: Both treatments were associated with higher primordial and secondary follicle numbers, fewer atretic follicles, higher estradiol, higher Esr1, Fshr, and Sod2 expression, lower Casp3 and Mct4 expression, and lower Caspase-3 and higher Ki-67 immunoreactivity relative to aged controls. Anti-Müllerian hormone, Nrf2, and Tomm20 were higher only with MSC-Mito@Alg; corpus luteum counts were higher only with MSC-Mito. Although empty capsules were not inert, peri-ovarian mitochondrial administration improved follicular, endocrine, and molecular indices of ovarian aging. Conclusions: The encapsulated formulation was associated with additional effects on antioxidant and mitochondrial-mass endpoints but was not uniformly superior to free mitochondria.
- 20 October 2026
- Published by MDPI AG in Biomedicines
- Vol. 14 (10) , 2394
Open AccessPeri-Ovarian Mitochondrial Administration Improves Surrogate Markers of Ovarian Function in Aged Rats: Free Versus Alginate-Encapsulated Mesenchymal Stromal Cell-Derived Mitochondria
Background: Ovarian aging is driven in part by mitochondrial dysfunction, and transfer of exogenous mitochondria has been proposed as a cell-free alternative to stem cell therapy; whether the delivery format alters efficacy has not been tested directly. Methods: We compared free and alginate-encapsulated mitochondria isolated from rat bone marrow-derived mesenchymal stromal cells (BM-MSCs) in aged rats. Mitochondria retained their membrane potential after encapsulation; approximately 35% of the encapsulated protein was released within 1 h in vitro, and release was complete by 24 h. Thirty-five female Wistar rats were allocated to five groups (n = 7): young control (Y-Ctrl), aged control (O-Ctrl), and three aged subgroups receiving empty capsules (Alg), free mitochondria (MSC-Mito), or encapsulated mitochondria (MSC-Mito@Alg), administered peri-ovarianly and evaluated on day 14. Results: Both treatments were associated with higher primordial and secondary follicle numbers, fewer atretic follicles, higher estradiol, higher Esr1, Fshr, and Sod2 expression, lower Casp3 and Mct4 expression, and lower Caspase-3 and higher Ki-67 immunoreactivity relative to aged controls. Anti-Müllerian hormone, Nrf2, and Tomm20 were higher only with MSC-Mito@Alg; corpus luteum counts were higher only with MSC-Mito. Although empty capsules were not inert, peri-ovarian mitochondrial administration improved follicular, endocrine, and molecular indices of ovarian aging. Conclusions: The encapsulated formulation was associated with additional effects on antioxidant and mitochondrial-mass endpoints but was not uniformly superior to free mitochondria.
- 30 September 2019
- Published by Journal of Biotechnology and Strategic Health Research in JOURNAL OF BIOTECHNOLOGY AND STRATEGIC HEALTH RESEARCH
- Vol. 3, 13-21
Türkiye ‘de Bitkisel Tıbbi Ürünler (Türkiye’de Bitkisel Ürünlerin Standardizasyonu, Üretimi Ve Tağşiş)
Fitoterapinin dünyadaki tarihsel gelişimi birçok çalışmada defalarca vurgulanmıştır. Ülkemizde ise getat mevzuatıyla beraber popülaritesi artan bir bilim dalı haline gelmiştir. Fitoterapi eğitimleri yıllardır Eczacılık Fakültelerinde Farmakognozi Anabilim dalı adı altında verilmekteydi. T.C Sağlık Bakanlığı’nın 2014 Geleneksel ve Tamamlayıcı Tıp (GETAT) mevzuatıyla beraber, yetki verilen üniversitelerce eğitimler yaygınlaştırılmış, eğitim alan hekim ve eczacı sayısı hızla artmıştır. Sonuçta hedef insan sağlığı ve tedavi olunca, fitoterapinin de gelişigüzel uygulanması düşünülemeyeceğinden, kanıta dayalı fitoterapi konusu gündeme gelmiştir ki; bunu da doğru endikasyonda, uygun dozda istenen maximum etki ve her uygulamada aynı etki şeklinde açıklamak doğru olacaktır. Bu noktada kullanılacak bitkisel ürünlerde kalite ve standardizasyonun önemi iyice belirginleşmektedir. Bu nedenle bu çalışmada bitkinin yetiştirilme sürecinden, drog ve ilaç haline gelinceye ve de artık uygulama ve tedavi boyutunda olması gereken kalite ve standardizasyon konusuna vurgu yapılması amaçlanmıştır.
- 30 September 2019
- Published by Journal of Biotechnology and Strategic Health Research in JOURNAL OF BIOTECHNOLOGY AND STRATEGIC HEALTH RESEARCH
- Vol. 3, 13-21
Türkiye ‘de Bitkisel Tıbbi Ürünler (Türkiye’de Bitkisel Ürünlerin Standardizasyonu, Üretimi Ve Tağşiş)
Fitoterapinin dünyadaki tarihsel gelişimi birçok çalışmada defalarca vurgulanmıştır. Ülkemizde ise getat mevzuatıyla beraber popülaritesi artan bir bilim dalı haline gelmiştir. Fitoterapi eğitimleri yıllardır Eczacılık Fakültelerinde Farmakognozi Anabilim dalı adı altında verilmekteydi. T.C Sağlık Bakanlığı’nın 2014 Geleneksel ve Tamamlayıcı Tıp (GETAT) mevzuatıyla beraber, yetki verilen üniversitelerce eğitimler yaygınlaştırılmış, eğitim alan hekim ve eczacı sayısı hızla artmıştır. Sonuçta hedef insan sağlığı ve tedavi olunca, fitoterapinin de gelişigüzel uygulanması düşünülemeyeceğinden, kanıta dayalı fitoterapi konusu gündeme gelmiştir ki; bunu da doğru endikasyonda, uygun dozda istenen maximum etki ve her uygulamada aynı etki şeklinde açıklamak doğru olacaktır. Bu noktada kullanılacak bitkisel ürünlerde kalite ve standardizasyonun önemi iyice belirginleşmektedir. Bu nedenle bu çalışmada bitkinin yetiştirilme sürecinden, drog ve ilaç haline gelinceye ve de artık uygulama ve tedavi boyutunda olması gereken kalite ve standardizasyon konusuna vurgu yapılması amaçlanmıştır.